Global Perspectives on Biomarker-Driven Therapeutic Strategies in Pancreatic Cancer

In this engaging satellite symposium renowned pancreatic cancer experts review and discuss key clinical data and patient case studies. They provide recommendations on biomarker strategies to guide treatment and look ahead at promising agents that may soon change practice.

Share

Program Content

Activities

Biomarker drivers in PaCa
Global Perspectives on Biomarker-Driven Therapeutic Strategies in Pancreatic Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 20, 2021

Expires: January 19, 2022

BRCA mutation Tx in PaCa
Therapeutic Approaches for PDAC Harboring BRCA Mutations and HRD
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 21, 2021

Expires: January 20, 2022

<i>EP</i>: Biomarkers in PDAC
ExpressPoints Biomarker-Driven Therapeutic Strategies in Pancreatic Cancer: Global Perspectives on Current Management, Challenges and Future Promise
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2021

Expires: January 26, 2022

Activities

Pancreatic cancer therapies
Global Perspectives on Biomarker-Driven Therapeutic Strategies in Pancreatic Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 15, 2021

Expires: March 14, 2022

Faculty

cover img faculity

Dirk Arnold, MD, PhD

Director
Asklepios Tumorzentrum Hamburg
Department of Oncology
AK Altona
Hamburg, Germany

cover img faculity

Philip Agop Philip, MD, PhD, FRCP

Professor
School of Medicine
Wayne State University
Leader, Gastrointestinal Multidisciplinary Team
Department of Oncology
Karmanos Cancer Institute
Detroit, Michigan

Supporters

Supported by an educational grant from

AstraZeneca